Status:
TERMINATED
Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AG
Lead Sponsor:
Rabin Medical Center
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The present study is aimed to evaluate the feasibility of a new noninvasive method to measure continuous glucose values using electromagnetic radiation.
Detailed Description
The non invasive continuous glucose sensing system of Physical Logic is based on a vector network analyzer (VNA), which monitor blood glucose through propriety sensors.Dielectric spectroscopy is an an...
Eligibility Criteria
Inclusion
- Signing an inform consent form
- Type 1 diabetes diagnosed at least 12 months prior to study inclusion
- Age \> 18 years old
- Willing to perform all study related procedures
Exclusion
- Known or suspected allergy to the sensor or one of its components
- Psychiatric disorder
- Patients with one or more of the following diseases: malignancy, myocardial insufficiency, nephrologic disease or any other chronic disease
- Patients who are not willing or are not capable of performing the protocol requirements
- Participating in another study that includes investigational drug or investigational equipment
- Pregnancy
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01247649
Start Date
November 1 2010
End Date
February 1 2011
Last Update
November 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schneider Children's Medical center
Petah Tikva, Israel, 49202